BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/18/2024 9:29:50 AM | Browse: 79 | Download: 298
 |
Received |
|
2024-02-28 10:49 |
|
Peer-Review Started |
|
2024-02-28 10:49 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2024-04-03 08:56 |
|
Revised |
|
2024-04-23 01:55 |
|
Second Decision |
|
2024-05-10 02:37 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2024-05-10 07:16 |
|
Articles in Press |
|
2024-05-10 07:16 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2024-06-03 05:47 |
|
Publish the Manuscript Online |
|
2024-06-18 09:29 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Retrospective Study |
| Article Title |
Effect of cetuximab plus FOLFOX4 regimen on clinical outcomes in advanced gastric carcinoma patients receiving evidence-based care
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Hui Ying, Xiao-Min Jing, Yan Li, Qun-Qiu Tong and Ren-Jun Huang |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Ren-Jun Huang, Doctor, Associate Chief Physician, Department of Oncology, Yongkang First People's Hospital, No. 599 Jinshan West Road, Yongkang 321300, Zhejiang Province, China. 13758992301@163.com |
| Key Words |
Cetuximab; FOLFOX4 regimen; Evidence-based care; Advanced gastric carcinoma; Efficacy and safety |
| Core Tip |
This study primarily analyzes the effect of cetuximab in combination with FOLFOX4 regimen (infusional fluorouracil, folinic acid, and oxaliplatin) as first-line therapy on the clinical outcomes of patients with advanced gastric carcinoma receiving evidence-based care. Based on the efficacy, serum tumor markers (STMs), inflammatory indicators, and improvement in quality of life (QOL), first-line treatment with cetuximab combined with the FOLFOX4 regimen has a profound effect on patients with advanced gastric carcinoma receiving evidence-based care, without increasing adverse drug effects, which is conducive to inhibiting STMs, ameliorating the serum inflammatory microenvironment, and enhancing patient QOL. |
| Publish Date |
2024-06-18 09:29 |
| Citation |
<p>Ying H, Jing XM, Li Y, Tong QQ, Huang RJ. Effect of cetuximab plus FOLFOX4 regimen on clinical outcomes in advanced gastric carcinoma patients receiving evidence-based care. <i>World J Clin Cases</i> 2024; 12(18): 3360-3367</p> |
| URL |
https://www.wjgnet.com/2307-8960/full/v12/i18/3360.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v12.i18.3360 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
